Use access key #2 to skip to page content.
$1.77 0.02 (1.27%)
8/29/2008 4:00 PM

La Jolla Pharmaceutical Company (LJPC)

CAPS Rating:
**

A biopharmaceutical company dedicated to improving and preserving human life by developing innovative pharmaceutical products.

Rating a stock in CAPS consists of three components:

Your call - Will this stock outperform or underperform the S&P 500? Successful picks are measured in terms of whether or not you were correct and by how many percentage points.

Your time frame - A guideline for other members to see whether your thinking is short or long-term. Time frame is also used to calculate the stock rating, but is not used in the scoring of your pick.

Your pitch - Here's your chance to offer more detailed thoughts, analysis, concerns, or the rationale behind your call. The pitch is optional and may be added later.

Each time you rate a stock, CAPS updates the community intelligence for the company, which may or may not change its CAPS rating. For more information, visit the Help tab at the top of the page.

Ticker Not Ratable

LJPC doesn't currently meet the $100M market cap / $1.50 stock price minimum. (Learn More)

What the Community Thinks

Total Members

66 Outperforms
17 Underperforms
 

All-Stars

16 Outperforms
8 Underperforms
 

Wall Street

3 Outperforms
1 Underperforms
 

Members bullish on LJPC are also bullish on:

Members bearish on LJPC are also bearish on:

Ticker Tags

Biotechnology (294), Micro Cap (4824)
Suggest a tag

La Jolla Pharmaceutical Company At A Glance

Current Price: $1.77
Last Trade Time: 8/29/2008 4:00 PM
Open: $1.78
Previous Close: $1.77
Daily Range: $1.75 - $1.85
52-Week Range: $1.45 - $4.71
Volume: 68,431
Market Cap: $97.93M
P/E Ratio: 0.00
Compare Our Special Broker Offers!

Stock Trends

LJPC VS S&P 500 (SPY)

LJPC 12 month chart vs. S&P

News & Discussion Boards

Other News Headlines for LJPC

More Headlines...

Top Bull Pitch

Recs

1

La Jolla Pharmaceutical Company (LJPC)

Avatar gklein711 (41.35) Submitted: 1/01/08 8:57 AM

Insiders bought all of new offering, but the stock went down from their buy-in pooint. It has now stabilized and should build from its' new bottom.

Replies: 0 | Reply | Permalink

Top Bear Pitch

Recs

1

La Jolla Pharmaceutical Company (LJPC)

Avatar zzlangerhans (90.55) Submitted: 7/05/07 2:56 AM

The clock is ticking on Riquent which will fail this phase III as it did in previous trials. This is a classic example of a company clinging to a single doomed product in order to extend the careers of the board and top management. I expect "shock and disappointment" when the negative interim result...More

Replies: 0 | Reply | Permalink

CAPS Members

picks per page. CHANGE

Results 1 - 5 of 18 :   1 2 3 4 Next »

Recs

0

 (LJPC)

Avatar chickenghost (< 20) Submitted: 7/18/08 6:08 PM : Outperform Start Price: $2.07 LJPC Score: -16.87

biotech

Report this Post Replies: 0 | Reply | Permalink

Recs

1

 (LJPC)

Avatar gklein711 (41.35) Submitted: 1/01/08 8:57 AM : Outperform Start Price: $3.89 LJPC Score: -42.39

Insiders bought all of new offering, but the stock went down from their buy-in pooint. It has now stabilized and should build from its' new bottom.

Report this Post Replies: 0 | Reply | Permalink

Recs

0

 (LJPC)

Avatar serenityman (66.57) Submitted: 8/04/07 2:40 PM : Outperform Start Price: $4.38 LJPC Score: -48.90

Insiders buy lots of shares .

Report this Post Replies: 0 | Reply | Permalink

Recs

0

 (LJPC)

Avatar aaroger (< 20) Submitted: 7/20/07 2:08 PM : Outperform Start Price: $4.31 LJPC Score: -42.55

5

Report this Post Replies: 0 | Reply | Permalink

Recs

1

 (LJPC)

Avatar zzlangerhans (90.55) Submitted: 7/05/07 2:56 AM : Underperform Start Price: $4.45 LJPC Score: 44.73

The clock is ticking on Riquent which will fail this phase III as it did in previous trials. This is a classic example of a company clinging to a single doomed product in order to extend the careers of the board and top management. I expect "shock and disappointment" when the negative interim results are released in 2008.

Report this Post Replies: 0 | Reply | Permalink

Results 1 - 5 of 18 :   1 2 3 4 Next »

Wall Street

Results 1 - 4 of 4  

picks per page. CHANGE

Top
Pick
Member NameMember RatingStart
Date
CallTime FrameStart
Price
Stock
Gain
S&P
Gain
ScorePitch
TrackSusquehanna 30.14 12/07/07 Outperform NS $4.00-55.75%-14.95%-40.80
TrackLazardCapit 89.74 06/13/07 Underperform NS $4.77-62.90%-14.55%+48.35
TrackAGEdwards 94.84 04/10/07 Outperform NS $7.91-77.62%-10.77%-66.86
TrackCanaccord 95.96 03/14/07 Outperform NS $7.42-76.15%-6.80%-69.34

Results 1 - 4 of 4  

Beat this Stock

Clicking "Beat this Stock!" will bring you to a company with a higher rating than the one you're currently viewing.

Even though CAPS shows only one- to five-star rankings, behind the scenes, all companies in CAPS have a distinct numerical ranking. In other words, there is a No. 1 stock in CAPS and a worst-ranked stock in CAPS. When you arrive at the top-ranked stock, clicking "Beat this Stock!" will cause the page to refresh.

That is, until there is a new No. 1 stock!

These companies do not represent formal Motley Fool recommendations. Please do your own due diligence before investing. Fool on.

Featured Broker Partners